APA (7th ed.) Citation

GI, R., RE, J., EK, O., ML, S., & DJ, B. (2002). Phase I clinical trials of tezacitabine [(E)-2'-deoxy-2'-(fluoromethylene)cytidine] in patients with refractory solid tumors. Clinical cancer research : an official journal of the American Association for Cancer Research, 8(9), 2828.

Chicago Style (17th ed.) Citation

GI, Rodriguez, Jones RE, Orenberg EK, Stoltz ML, and Brooks DJ. "Phase I Clinical Trials of Tezacitabine [(E)-2'-deoxy-2'-(fluoromethylene)cytidine] in Patients with Refractory Solid Tumors." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 8, no. 9 (2002): 2828.

MLA (9th ed.) Citation

GI, Rodriguez, et al. "Phase I Clinical Trials of Tezacitabine [(E)-2'-deoxy-2'-(fluoromethylene)cytidine] in Patients with Refractory Solid Tumors." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 8, no. 9, 2002, p. 2828.